Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,136
Closed -$395K 247
2025
Q4
$395K Sell
3,136
-519,095
-99% -$67.7M ﹤0.01% 212
2025
Q3
$75.6M Buy
522,231
+202,516
+63% +$30.6M 0.74% 34
2025
Q2
$50.1M Buy
319,715
+15,261
+5% +$2.42M 0.65% 35
2025
Q1
$50M Buy
304,454
+3,112
+1% +$518K 0.69% 35
2024
Q4
$48.6M Buy
301,342
+3,977
+1% +$711K 0.66% 37
2024
Q3
$57.7M Buy
297,365
+16,139
+6% +$2.97M 0.79% 32
2024
Q2
$49.2M Buy
281,226
+20,179
+8% +$3.36M 0.74% 34
2024
Q1
$44.2M Buy
261,047
+13,652
+6% +$2.56M 0.66% 33
2023
Q4
$49M Buy
247,395
+11,701
+5% +$2.07M 0.81% 30
2023
Q3
$41M Buy
235,694
+3,068
+1% +$557K 0.74% 27
2023
Q2
$40.2M Buy
232,626
+2,445
+1% +$423K 0.82% 24
2023
Q1
$38.4M Buy
+230,181
New +$37.7M 0.86% 23

Other funds holding ZTS

ABN AMRO Bank's ZTS Position: Q1 2026 in Review

ABN AMRO Bank sold out of Zoetis (ZTS) in Q1 2026, closing a stake of 3,136 shares — an estimated $395K sold.

ABN AMRO Bank first reported a position in ZTS in Q1 2023 and held it in 12 quarters. The position peaked at $75.6M in Q3 2025. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • ABN AMRO Bank reported no remaining Zoetis position as of Q1 2026 after selling out during the quarter.
  • ABN AMRO Bank sold 3,136 Zoetis shares in Q1 2026, an estimated $395K.
  • ABN AMRO Bank first reported a position in Zoetis in Q1 2023 and held it in 12 quarters.
  • ABN AMRO Bank's Zoetis position peaked at $75.6M in Q3 2025.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on ABN AMRO Bank's 13F filing for Q1 2026, filed 22 Apr 2026.